Is Oncoclínicas do Brasil stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Oncoclínicas do Brasil 10 years ago, but if you had invested on Tuesday 21st of September 2021 when the price was BRL14.77, you would have made a loss of BRL-9.57 per share or -64.79%
Yes, the average daily trading liquidity for Oncoclínicas do Brasil is BRL4.43 million. You should therefore be able to get in and out of your positions relatively fast.
Oncoclínicas do Brasil has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.01, the company's ability to pay off the debt is limited. The company has a very low net profit margin of 3.73%, which is challenging.
We have calculated the inflation risk for Oncoclínicas do Brasil to be medium [0.65 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.